The trademark ABEQUO was filed by TEVA PHARMACEUTICALS USA, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on March 23, 2022, and received one opposition filed on June 23, 2022 by Novartis AG on Likelihood of confusion. the opponent was represented by MILOJEVIC, SEKULIC & ASSOCIATES, S.L. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued June 23, 2022
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).